Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2.

Young NP, Daube JR, Sorenson EJ, Milone M.

Muscle Nerve. 2010 Jun;41(6):758-62. doi: 10.1002/mus.21615.

PMID:
20513102
2.

Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.

Logigian EL, Ciafaloni E, Quinn LC, Dilek N, Pandya S, Moxley RT 3rd, Thornton CA.

Muscle Nerve. 2007 Apr;35(4):479-85.

PMID:
17230537
3.

Myotonic dystrophy type 2 and related myotonic disorders.

Meola G, Moxley RT 3rd.

J Neurol. 2004 Oct;251(10):1173-82. Review.

PMID:
15503094
4.

Does quantitative EMG differ myotonic dystrophy type 2 and type 1?

Szmidt-Salkowska E, Gawel M, Lusakowska A, Nojszewska M, Lipowska M, Sulek A, Krysa W, Rajkiewicz M, Seroka A, Kaminska AM.

J Electromyogr Kinesiol. 2014 Oct;24(5):755-61. doi: 10.1016/j.jelekin.2014.05.012. Epub 2014 Jun 25.

PMID:
25052913
5.

Myotonic dystrophy type 2 with focal asymmetric muscle weakness and no electrical myotonia.

Milone M, Batish SD, Daube JR.

Muscle Nerve. 2009 Mar;39(3):383-5. doi: 10.1002/mus.21150.

PMID:
19208413
6.

Proximal myopathy and diffuse white matter involvement in myotonic dystrophy type I.

Uluc K, Arsava EM, Erdem S, Tan E.

J Neurol. 2002 May;249(5):629-30. No abstract available.

PMID:
12021957
7.

Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.

Nadaj-Pakleza A, Lusakowska A, Sułek-Piątkowska A, Krysa W, Rajkiewicz M, Kwieciński H, Kamińska A.

Folia Morphol (Warsz). 2011 May;70(2):121-9.

PMID:
21630234
8.

Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.

Cardani R, Mancinelli E, Sansone V, Rotondo G, Meola G.

Eur J Histochem. 2004 Oct-Dec;48(4):437-42.

PMID:
15718211
9.

Proximal myotonic myopathy: clinical, neuropathologic, and molecular genetic features.

Eisenschenk S, Triggs WJ, Pearl GS, Rojiani AM.

Ann Clin Lab Sci. 2001 Apr;31(2):140-6.

PMID:
11337902
10.

Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.

Dabby R, Sadeh M, Herman O, Leibou L, Kremer E, Mordechai S, Watemberg N, Frand J.

Isr Med Assoc J. 2011 Dec;13(12):745-7.

11.

Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2).

Day JW, Roelofs R, Leroy B, Pech I, Benzow K, Ranum LP.

Neuromuscul Disord. 1999 Jan;9(1):19-27.

PMID:
10063831
12.

Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.

Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, Thornton CA, Moxley RT, Harper PS, Rogers MT, Jurkat-Rott K, Lehmann-Horn F, Wieser T, Gamez J, Navarro C, Bottani A, Kohler A, Shriver MD, Sallinen R, Wessman M, Zhang S, Wright FA, Krahe R.

Am J Hum Genet. 2003 Oct;73(4):835-48. Epub 2003 Sep 10.

13.

The expanding clinical and genetic spectrum of the myotonic dystrophies.

Ricker K.

Acta Neurol Belg. 2000 Sep;100(3):151-5.

PMID:
11098287
14.

Clinical and genetic heterogeneity in myotonic dystrophies.

Meola G.

Muscle Nerve. 2000 Dec;23(12):1789-99. Review.

PMID:
11102902
15.

A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.

Le Ber I, Martinez M, Campion D, Laquerrière A, Bétard C, Bassez G, Girard C, Saugier-Veber P, Raux G, Sergeant N, Magnier P, Maisonobe T, Eymard B, Duyckaerts C, Delacourte A, Frebourg T, Hannequin D.

Brain. 2004 Sep;127(Pt 9):1979-92. Epub 2004 Jun 23.

PMID:
15215218
16.

[Myotonic dystrophy type 2].

Kimura T, Saito T.

Brain Nerve. 2011 Nov;63(11):1151-60. Review. Japanese.

PMID:
22068467
17.

Fluoxetine blocks myotonic runs and reverts abnormal surface electromyogram pattern in patients with myotonic dystrophy type 1.

Chisari C, Licitra R, Pellegrini M, Pellegrino M, Rossi B.

Clin Neuropharmacol. 2009 Nov-Dec;32(6):330-4. doi: 10.1097/WNF.0b013e3181ae5546.

PMID:
19667977
18.

Musculoskeletal pain in patients with myotonic dystrophy type 2.

George A, Schneider-Gold C, Zier S, Reiners K, Sommer C.

Arch Neurol. 2004 Dec;61(12):1938-42.

PMID:
15596616
19.

New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).

Sallinen R, Vihola A, Bachinski LL, Huoponen K, Haapasalo H, Hackman P, Zhang S, Sirito M, Kalimo H, Meola G, Horelli-Kuitunen N, Wessman M, Krahe R, Udd B.

Neuromuscul Disord. 2004 Apr;14(4):274-83.

PMID:
15019706
20.

Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM).

Flachenecker P, Schneider C, Cursiefen S, Ricker K, Toyka KV, Reiners K.

Neuromuscul Disord. 2003 May;13(4):289-93.

PMID:
12868497

Supplemental Content

Support Center